These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Schizophrenia in clinical imaging; anomalies in brain anatomy and metabolism]. Hulshoff Pol HE; Baaré WF; Mali WP; van Ree JM; Kahn RS Ned Tijdschr Geneeskd; 1995 Mar; 139(10):494-7. PubMed ID: 7891755 [No Abstract] [Full Text] [Related]
3. Searching for the neuropathology of schizophrenia: neuroimaging strategies and findings. Lieberman JA Am J Psychiatry; 1999 Aug; 156(8):1133-6. PubMed ID: 10450250 [No Abstract] [Full Text] [Related]
4. Dysregulation of dopamine and pathology of prefrontal neurons: neuroimaging studies in schizophrenia and related animal models. Bertolino A Epidemiol Psichiatr Soc; 1999; 8(4):248-54. PubMed ID: 10709315 [No Abstract] [Full Text] [Related]
5. Structural and functional brain imaging in schizophrenia. Cleghorn JM; Zipursky RB; List SJ J Psychiatry Neurosci; 1991 Jul; 16(2):53-74. PubMed ID: 1911736 [TBL] [Abstract][Full Text] [Related]
6. [Brain imaging in schizophrenia -- especially by Computed Tomography]. Szulc A Psychiatr Pol; 1994; 28(2):145-56. PubMed ID: 8208861 [TBL] [Abstract][Full Text] [Related]
7. Elevated D2 in schizophrenia: role of endogenous dopamine and cerebellum. Commentary on "The current status of PET scanning with respect to schizophrenia". Seeman P Neuropsychopharmacology; 1992 Aug; 7(1):55-7; discussion 73-5. PubMed ID: 1388022 [No Abstract] [Full Text] [Related]
9. [Structural and functional cerebral changes in patients with schizophrenia]. Rubin PJ; Hemmingsen RP Ugeskr Laeger; 1993 Jan; 155(1):16-21. PubMed ID: 8421841 [TBL] [Abstract][Full Text] [Related]
10. The biochemistry of schizophrenia--a review. Shelley RK; Walsh N Ir Med J; 1985 May; 78(5):139-43. PubMed ID: 3891675 [No Abstract] [Full Text] [Related]
11. Imaging dopamine transmission in schizophrenia. A review and meta-analysis. Laruelle M Q J Nucl Med; 1998 Sep; 42(3):211-21. PubMed ID: 9796369 [TBL] [Abstract][Full Text] [Related]
12. Functional neuroimaging in psychiatry. Fu CH; McGuire PK Philos Trans R Soc Lond B Biol Sci; 1999 Jul; 354(1387):1359-70. PubMed ID: 10466156 [TBL] [Abstract][Full Text] [Related]
13. Commentary on "The current status of PET scanning with respect to schizophrenia". Buchsbaum MS Neuropsychopharmacology; 1992 Aug; 7(1):67-8; discussion 73-5. PubMed ID: 1355970 [No Abstract] [Full Text] [Related]
14. PET scanning in schizophrenia, a critical evaluation. Commentary on "The current status of PET scanning with respect to schizophrenia". Murphy D; Rapoport SI Neuropsychopharmacology; 1992 Aug; 7(1):59-61; discussion 73-5. PubMed ID: 1524656 [No Abstract] [Full Text] [Related]
15. PET studies of neuroreceptors in schizophrenia. Commentary on "The current status of PET scanning with respect to schizophrenia". Wong DF Neuropsychopharmacology; 1992 Aug; 7(1):69-72; discussion 73-5. PubMed ID: 1388023 [No Abstract] [Full Text] [Related]
18. Magnetic resonance imaging, positron emission tomography, and single-photon-emission computed tomography in epilepsy. Chong BW; Shelton DK West J Med; 1996; 165(1-2):53-4. PubMed ID: 8855687 [No Abstract] [Full Text] [Related]
19. [Use of modern brain imaging methods in psychiatry]. Ondriásová M Bratisl Lek Listy; 1990 Oct; 91(10):790-3. PubMed ID: 2253048 [TBL] [Abstract][Full Text] [Related]
20. [First and second generation antipsychotics and morphological and neurochemical brain changes in schizophrenia. Review of magnetic resonance imaging and proton spectroscopy findings]. Szulc A Psychiatr Pol; 2007; 41(3):329-38. PubMed ID: 17900049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]